Source - LSE Regulatory
RNS Number : 2997R Canal+ S.A 24 December 2024 24 December 2024 Canal+ SA (the "Company") Director/PDMR Shareholding The Company was notified on 23 December 2024 that Maxime Saada, Chairman of the Management Board and Chief Executive Officer of the Company, acquired 77,000 ordinary shares of €0.25 each ("Shares") in the Company on 19 December 2024. The Company was also notified on 23 December 2024 that Charles Billard, a person closely associated to Amandine Ferré, a member of the Management Board of the Company, acquired 25,100 Shares in the Company on 20 December 2024. The notifications below, made in accordance with the requirements of Article 19(3) of the UK Market Abuse Regulation, provide further detail. It is also noted that the announcement made by the Company at 12:33:26 (RNS Number: 9743Q) on 20 December 2024 in relation to Vivendi SE's disposal of 146,996 Shares on 18 December 2024 referred in error to "EUR" rather than "GBP", as a result a revised notification is stated below. Enquiries: For investor enquiries ir@canal-plus.com For media enquiries elvire.charbonnel@canal-plus.com olivia.abehassera@canal-plus.com Notification and public disclosure of transactions by persons discharging managerial responsibilities Amendment in relation to Previous Announcement with RNS Number 9743Q Notification and public disclosure of transactions by persons discharging managerial responsibilities This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHGCBDDUUDDGSS